PIQRAY cpr pell 200mg+50mg 56 pce

7680673590041 CH-67359 L01EM03 07.16.1.

Reimbursement limitations:

PIQRAY

En combinaison uniquement avec fulvestrant pour le traitement des femmes ménopausées avec un cancer du …

PIQRAY cpr pell 200mg+50mg 56 pce
PIQRAY cpr pell 200mg+50mg 56 pce
PIQRAY cpr pell 200mg+50mg 56 pce
1 / 3
google

Details

Product number
6735903
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
I) 200 mg: alpelisibum 200 mg, cellulosum microcristallinum, mannitolum, carboxymethylamylum natricum A corresp. natrium 0.84 mg, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum, talcum, E 171, E 172, pro compresso obducto. II) 50 mg: alpelisibum 50 mg, cellulosum microcristallinum, mannitolum, carboxymethylamylum natricum A corresp. natrium 0.21 mg, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum, talcum, E 171, E 172, pro compresso obducto.

Articles (1)

Piqray 200 mg + 50 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/03/2025
Patient information leaflet
Français
11/03/2025
Patient information leaflet
Italien
11/03/2025
Professional SmPC
Allemand
11/03/2025
Professional SmPC
Français
11/03/2025
Professional SmPC
Italien
11/03/2025

Detailed composition

Substance Quantity Type Category
II
50.0 MG Substance Wirkstoff (Principe actif)
I
200.0 MG Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
0.84 MG Substance HBESI
II
0.21 MG Substance HBESI
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance FNIDK
II
- Substance FNIDK
II
- Substance FTODK
I
- Substance FTODK

Reimbursement information

Public price
CHF 3259.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2021

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67359
Drug name
Piqray, Filmtabletten
Galenic form
FILM
ATC Code
L01EM03
Authorization status
Z
Dispensation category
A
First authorization
24/03/2020
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
In Kombination mit Fulvestrant zur Behandlung von HR-positivem, HER2-negativem fortgeschrittenem Brustkrebs mit einer PIK3CA-Mutation

Packaging details

Description (FR)
PIQRAY cpr pell 200mg+50mg 56 pce
Description (DE)
PIQRAY Filmtabl 200mg+50mg 56 Stk
Market launch
24/03/2020
Narcotic (BTM)
No

Other packaging sizes

PIQRAY cpr pell 150 mg 28 pce
28 TABL
View
PIQRAY cpr pell 150 mg 56 pce
56 TABL
View
PIQRAY cpr pell 200mg+50mg 28 pce
14 TABL
View
PIQRAY cpr pell 200 mg 28 pce
28 TABL
View